Liangshan Da
No.120 Wan Shui Road
Hefei, 230022, China
Hefei, 230022, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Construction and validation of a prognostic nomogram for advanced esophageal squamous cell carcinoma patients treated with PD-1 inhibitor-based therapy.
Journal: Discover oncology
Published: August 11, 2025
Correlative analysis of immune-related thyroid dysfunction and prognosis in patients with advanced esophageal squamous cell carcinoma.
Journal: Anti-cancer drugs
Published: March 20, 2025
A retrospective study on the efficacy and safety of Envafolimab, a PD-L1 inhibitor, in the treatment of advanced malignant solid tumors.
Journal: Frontiers in pharmacology
Published: December 14, 2023
Prognostic value of inflammatory markers and clinical features for survival in advanced or metastatic esophageal squamous cell carcinoma patients receiving anti-programmed death 1 treatment.
Journal: Frontiers in oncology
Published: January 15, 2023
Effectiveness and safety of camrelizumab combined with chemotherapy in nonsquamous nonsmall cell lung cancer as the second-line therapy: A retrospective analysis.
Journal: Journal of cancer research and therapeutics
Published: June 01, 2022
Anlotinib plus nab-paclitaxel/gemcitabine as first-line treatment prolongs survival in patients with unresectable or metastatic pancreatic adenocarcinoma: a retrospective cohort.
Journal: Annals of translational medicine
Published: January 12, 2022
Safety and efficacy of sintilimab combination therapy for the treatment of 48 patients with advanced malignant tumors.
Journal: Translational cancer research
Published: September 22, 2021
Tumor Microenvironment Characteristics of Pancreatic Cancer to Determine Prognosis and Immune-Related Gene Signatures.
Journal: Frontiers in molecular biosciences
Published: December 22, 2020
Long Noncoding RNA PTPRG Antisense RNA 1 Reduces Radiosensitivity of Nonsmall Cell Lung Cancer Cells Via Regulating MiR-200c-3p/TCF4.
Journal: Technology in cancer research & treatment
Published: November 11, 2020
Circular RNA circ_SETD2 represses breast cancer progression via modulating the miR-155-5p/SCUBE2 axis.
Journal: Open medicine (Warsaw, Poland)
Published: February 18, 2020
Prognostic value of DNA aneuploidy in gastric cancer: a meta-analysis of 3449 cases.
Journal: BMC cancer
Published: March 23, 2018
Celecoxib potentially inhibits metastasis of lung cancer promoted by surgery in mice, via suppression of the PGE2-modulated β-catenin pathway.
Journal: Toxicology letters
Published: August 07, 2013
Last Updated: 09/26/2026